HIV-I
Vaccination as a means of disease prevention in HIV infected individuals; successes, challenges & opportunities
256
Human Immunodeficiency Virus (HIV) Vaccine Trials: a Novel Assay for Differential Diagnosis of HIV Infections in the Face of Vaccine-Generated Antibodies
8
Type I interferon responses are impaired in latently HIV infected cells
9
Pharmacologic and nonpharmacologic options for the management of HIV infection during pregnancy
13
Epidemiology and Clinical Characteristics of HIV Infected Patients in Kuala Lumpur
5
Common epitope in human immunodeficiency virus (HIV) I GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I infected individuals
7
Specific Inhibition of HIV Infection by the Action of Spironolactone in T Cells
9
Non Adherence to PMTCT Treatment and Loss to Follow Up of HIV Positive Mothers and Babies in Mombasa County, Kenya
77
cis Expression of the F12 Human Immunodeficiency Virus (HIV) Nef Allele Transforms the Highly Productive NL4-3 HIV Type 1 to a Replication-Defective Strain: Involvement of both Env gp41 and CD4 Intracytoplasmic Tails
10
Caveolin 1 reduces HIV 1 infectivity by restoration of HIV Nef mediated impairment of cholesterol efflux by apoA I
16
Nonneutralizing Functional Antibodies: a New “Old” Paradigm for HIV Vaccines
14
The impact of Highly Active Antiretroviral Therapy (HAART) on the clinical features of HIV - related oral lesions in Nigeria
6
Magnitude and Frequency of Cytotoxic T-Lymphocyte Responses: Identification of Immunodominant Regions of Human Immunodeficiency Virus Type 1 Subtype C
14
Benefit of Primary Prophylaxis Before 18 Months of Age in Reducing the Incidence of Pneumocystis carinii Pneumonia and Early Death in a Cohort of 112 Human Immunodeficiency Virus-infected Infants
8
Kyamakya
6
Inhibition of HIV Replication by Apolipoprotein A I Binding Protein Targeting the Lipid Rafts
20
The Myth of HIV Health Tourism
12
Hematological Profile of People Living with HIV/AIDS
79
Targeting IκB Proteins for HIV Latency Activation: the Role of Individual IκB and NF-κB Proteins
13
Sexual negotiation in the AIDS era: negotiated safety revisited
7